Review



recombinant bcan  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems recombinant bcan
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Recombinant Bcan, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/bio_rxiv__64898__2026__03__26__713760-254-27-31?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    recombinant bcan - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of “prime-and-kill” synNotch-CAR-T cells"

    Article Title: Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of “prime-and-kill” synNotch-CAR-T cells

    Journal: bioRxiv

    doi: 10.64898/2026.03.26.713760

    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 (BCAN + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Figure Legend Snippet: ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 (BCAN + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .

    Techniques Used: In Vitro, In Vivo, Expressing, Derivative Assay, Co-Culture Assay, Flow Cytometry, Quantitative RT-PCR, RNA Sequencing, Gene Expression



    Similar Products

    anti brevican mouse monoclonal antibody  (TaKaRa)
    97
    TaKaRa anti brevican mouse monoclonal antibody
    Anti Brevican Mouse Monoclonal Antibody, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/pm41430471-809-53-68?v=TaKaRa
    Average 97 stars, based on 1 article reviews
    anti brevican mouse monoclonal antibody - by Bioz Stars, 2026-07
    97/100 stars
    		  Buy from Supplier
    recombinant bcan  (R&D Systems)
    94
    R&D Systems recombinant bcan
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Recombinant Bcan, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/bio_rxiv__64898__2026__03__26__713760-254-27-31?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    recombinant bcan - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    recombinant human brevican  (R&D Systems)
    94
    R&D Systems recombinant human brevican
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Recombinant Human Brevican, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/pm41711854-38-0-6?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    recombinant human brevican - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    sheep anti brevican  (R&D Systems)
    93
    R&D Systems sheep anti brevican
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Sheep Anti Brevican, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/pm41707919-72-24-26?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    sheep anti brevican - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    si10 brevican  (Addgene inc)
    93
    Addgene inc si10 brevican
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Si10 Brevican, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/pm41430471-388-4-5?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    si10 brevican - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    mouse anti brevican  (TaKaRa)
    97
    TaKaRa mouse anti brevican
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Mouse Anti Brevican, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/pm41430471-387-10-16?v=TaKaRa
    Average 97 stars, based on 1 article reviews
    mouse anti brevican - by Bioz Stars, 2026-07
    97/100 stars
    		  Buy from Supplier
    rabbit anti brevican  (Novus Biologicals)
    93
    Novus Biologicals rabbit anti brevican
    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
    Rabbit Anti Brevican, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brevican/pm41366031-323-61-65?v=Novus+Biologicals
    Average 93 stars, based on 1 article reviews
    rabbit anti brevican - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 (BCAN + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .

    Journal: bioRxiv

    Article Title: Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of “prime-and-kill” synNotch-CAR-T cells

    doi: 10.64898/2026.03.26.713760

    Figure Lengend Snippet: ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 (BCAN + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .

    Article Snippet: To prepare the B-SYNC primed sample, 2 × 10 4 cells were cultured for 24 hours on wells coated with Laminin (100 μg/ml, Thermo Fisher Scientific,23017015) and recombinant BCAN (25 μg/ml; R&D Systems, 7188-BC-050 and 4009-BC-050).

    Techniques: In Vitro, In Vivo, Expressing, Derivative Assay, Co-Culture Assay, Flow Cytometry, Quantitative RT-PCR, RNA Sequencing, Gene Expression